{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T06:28:04Z","timestamp":1781677684676,"version":"3.54.5"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T00:00:00Z","timestamp":1752278400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title>\n          <jats:p>Tumor associated neutrophils (TANs) exert dual and opposing functions in tumors, acting pro-tumorigenic and anti-tumorigenic, depending on tumor progression, polarization state and subtype. Consequently, the prognostic impact of TANs in breast cancer is also contradictory. Since neutrophils are critically needed to fight infections in cancer patients, the mediators leading to tumor progression need more investigation as potential future targets. The neutrophil derived mediator myeloperoxidase (MPO) is a peroxidase with dual functions in tumors, acting both immune enhancing and suppressing. Patients with metastatic breast cancer (MBC) have aggressive tumors with a dismal prognosis and urgently need novel treatment strategies. Therefore, we here aimed to investigate the prognostic impact of TANs, MPO<jats:sup>+<\/jats:sup> TANs and MPO<jats:sup>+<\/jats:sup> non-neutrophils using a cohort with newly diagnosed MBC patients specifically. We show that high infiltration of MPO<jats:sup>+<\/jats:sup> TANs and MPO<jats:sup>+<\/jats:sup> non-neutrophils in the primary tumor (PT), was associated with clinicopathological features and worse prognosis in patients with MBC. However, only infiltration of MPO<jats:sup>+<\/jats:sup> TANs showed independent prognostic impact in multivariable analysis adjusting for other prognostic factors in MBC. The results need to be validated in a larger cohort but suggests that MPO targeting strategies could be relevant in breast cancer patients with aggressive disease.<\/jats:p>","DOI":"10.1038\/s41598-025-08854-x","type":"journal-article","created":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T16:26:28Z","timestamp":1752337588000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Myeloperoxidase expressing tumor associated neutrophils are associated with worse prognosis in metastatic breast cancer patients"],"prefix":"10.1038","volume":"15","author":[{"given":"Karin","family":"Leandersson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Blomg\u00e5rd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Tuvesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Bergenfelz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Maria","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,7,12]]},"reference":[{"key":"8854_CR1","doi-asserted-by":"publisher","first-page":"20211033","DOI":"10.1259\/bjr.20211033","volume":"95","author":"L Wilkinson","year":"2022","unstructured":"Wilkinson, L. & Gathani, T. Understanding breast cancer as a global health concern. Br. J. Radiol. 95, 20211033. https:\/\/doi.org\/10.1259\/bjr.20211033 (2022).","journal-title":"Br. J. Radiol."},{"key":"8854_CR2","doi-asserted-by":"publisher","unstructured":"Aysola, K. et al. Triple negative breast Cancer\u2014an overview. Hereditary Genet. 2013 (001). https:\/\/doi.org\/10.4172\/2161-1041.S2-001 (2013).","DOI":"10.4172\/2161-1041.S2-001"},{"key":"8854_CR3","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.3390\/curroncol28030168","volume":"28","author":"S Andrahennadi","year":"2021","unstructured":"Andrahennadi, S., Sami, A., Manna, M., Pauls, M. & Ahmed, S. Current landscape of targeted therapy in hormone Receptor-Positive and HER2-Negative breast Cancer. Curr. Oncol. 28, 1803\u20131822. https:\/\/doi.org\/10.3390\/curroncol28030168 (2021).","journal-title":"Curr. Oncol."},{"key":"8854_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s12276-018-0191-1","volume":"50","author":"P Darvin","year":"2018","unstructured":"Darvin, P., Toor, S. M., Sasidharan Nair, V. & Elkord, E. Immune checkpoint inhibitors: Recent progress and potential biomarkers. Exp. Mol. Med. 50, 1\u201311. https:\/\/doi.org\/10.1038\/s12276-018-0191-1 (2018).","journal-title":"Exp. Mol. Med."},{"key":"8854_CR5","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11523-020-00730-0","volume":"15","author":"LL Michel","year":"2020","unstructured":"Michel, L. L. et al. Immune checkpoint Blockade in patients with Triple-Negative breast Cancer. Target. Oncol. 15, 415\u2013428. https:\/\/doi.org\/10.1007\/s11523-020-00730-0 (2020).","journal-title":"Target. Oncol."},{"key":"8854_CR6","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1016\/j.canlet.2015.10.009","volume":"370","author":"H Tang","year":"2016","unstructured":"Tang, H., Qiao, J. & Fu, Y. X. Immunotherapy and tumor microenvironment. Cancer Lett. 370, 85\u201390. https:\/\/doi.org\/10.1016\/j.canlet.2015.10.009 (2016).","journal-title":"Cancer Lett."},{"key":"8854_CR7","doi-asserted-by":"publisher","unstructured":"Tang, T. et al. Advantages of targeting the tumor immune microenvironment over blocking immune checkpoint in cancer immunotherapy. Signal. Transduct. Target. Therapy. 6 https:\/\/doi.org\/10.1038\/s41392-020-00449-4 (2021).","DOI":"10.1038\/s41392-020-00449-4"},{"key":"8854_CR8","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.2217\/imt.13.102","volume":"5","author":"RZ Panni","year":"2013","unstructured":"Panni, R. Z., Linehan, D. C. & DeNardo, D. G. Targeting tumor-infiltrating macrophages to combat cancer. Immunotherapy 5, 1075\u20131087. https:\/\/doi.org\/10.2217\/imt.13.102 (2013).","journal-title":"Immunotherapy"},{"key":"8854_CR9","doi-asserted-by":"publisher","unstructured":"Kim, J. & Bae, J. S. Tumor-associated macrophages and neutrophils in tumor microenvironment. Mediators Inflamm. 6058147, (2016). https:\/\/doi.org\/10.1155\/2016\/6058147 (2016).","DOI":"10.1155\/2016\/6058147"},{"key":"8854_CR10","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1038\/s41571-019-0222-4","volume":"16","author":"ME Shaul","year":"2019","unstructured":"Shaul, M. E. & Fridlender, Z. G. Tumour-associated neutrophils in patients with cancer. Nat. Rev. Clin. Oncol. 16, 601\u2013620. https:\/\/doi.org\/10.1038\/s41571-019-0222-4 (2019).","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"8854_CR11","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","volume":"22","author":"CC Hedrick","year":"2022","unstructured":"Hedrick, C. C. & Malanchi, I. Neutrophils in cancer: Heterogeneous and multifaceted. Nat. Rev. Immunol. 22, 173\u2013187. https:\/\/doi.org\/10.1038\/s41577-021-00571-6 (2022).","journal-title":"Nat. Rev. Immunol."},{"key":"8854_CR12","doi-asserted-by":"publisher","first-page":"106996","DOI":"10.1016\/j.phrs.2023.106996","volume":"198","author":"YT Gong","year":"2023","unstructured":"Gong, Y. T. et al. Neutrophils as potential therapeutic targets for breast cancer. Pharmacol. Res. 198, 106996. https:\/\/doi.org\/10.1016\/j.phrs.2023.106996 (2023).","journal-title":"Pharmacol. Res."},{"key":"8854_CR13","doi-asserted-by":"publisher","first-page":"1779","DOI":"10.3389\/fimmu.2020.01779","volume":"11","author":"W Zhang","year":"2020","unstructured":"Zhang, W. et al. A Rosetta stone for breast cancer: Prognostic value and dynamic regulation of neutrophil in tumor microenvironment. Front. Immunol. 11, 1779. https:\/\/doi.org\/10.3389\/fimmu.2020.01779 (2020).","journal-title":"Front. Immunol."},{"key":"8854_CR14","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1309\/AJCP2E6QNDIDPTTC","volume":"139","author":"YW Koh","year":"2013","unstructured":"Koh, Y. W., Lee, H. J., Ahn, J. H., Lee, J. W. & Gong, G. Expression of Lewis X is associated with poor prognosis in triple-negative breast cancer. Am. J. Clin. Pathol. 139, 746\u2013753. https:\/\/doi.org\/10.1309\/AJCP2E6QNDIDPTTC (2013).","journal-title":"Am. J. Clin. Pathol."},{"key":"8854_CR15","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1177\/1066896908324668","volume":"16","author":"P Sozzani","year":"2008","unstructured":"Sozzani, P., Arisio, R., Porpiglia, M. & Benedetto, C. Is Sialyl Lewis x antigen expression a prognostic factor in patients with breast cancer? Int. J. Surg. Pathol. 16, 365\u2013374. https:\/\/doi.org\/10.1177\/1066896908324668 (2008).","journal-title":"Int. J. Surg. Pathol."},{"key":"8854_CR16","doi-asserted-by":"publisher","first-page":"111171","DOI":"10.1016\/j.celrep.2022.111171","volume":"40","author":"E Pylaeva","year":"2022","unstructured":"Pylaeva, E. et al. During early stages of cancer, neutrophils initiate anti-tumor immune responses in tumor-draining lymph nodes. Cell. Rep. 40, 111171. https:\/\/doi.org\/10.1016\/j.celrep.2022.111171 (2022).","journal-title":"Cell. Rep."},{"key":"8854_CR17","doi-asserted-by":"publisher","unstructured":"Zuo, H. et al. Targeting neutrophil extracellular traps: A novel antitumor strategy. J. Immunol. Res. 2023 (5599660). https:\/\/doi.org\/10.1155\/2023\/5599660 (2023).","DOI":"10.1155\/2023\/5599660"},{"key":"8854_CR18","doi-asserted-by":"publisher","first-page":"1170603","DOI":"10.3389\/fimmu.2023.1170603","volume":"14","author":"S Jaboury","year":"2023","unstructured":"Jaboury, S., Wang, K., O\u2019Sullivan, K. M., Ooi, J. D. & Ho, G. Y. NETosis as an oncologic therapeutic target: A mini review. Front. Immunol. 14, 1170603. https:\/\/doi.org\/10.3389\/fimmu.2023.1170603 (2023).","journal-title":"Front. Immunol."},{"key":"8854_CR19","doi-asserted-by":"publisher","first-page":"3649","DOI":"10.18632\/oncotarget.12278","volume":"8","author":"CR Millrud","year":"2017","unstructured":"Millrud, C. R., Bergenfelz, C. & Leandersson, K. On the origin of myeloid-derived suppressor cells. Oncotarget 8, 3649\u20133665. https:\/\/doi.org\/10.18632\/oncotarget.12278 (2017).","journal-title":"Oncotarget"},{"key":"8854_CR20","doi-asserted-by":"publisher","first-page":"3813","DOI":"10.1007\/s00018-013-1286-4","volume":"70","author":"J Pillay","year":"2013","unstructured":"Pillay, J., Tak, T., Kamp, V. M. & Koenderman, L. Immune suppression by neutrophils and granulocytic myeloid-derived suppressor cells: Similarities and differences. Cell. Mol. Life Sci. 70, 3813\u20133827. https:\/\/doi.org\/10.1007\/s00018-013-1286-4 (2013).","journal-title":"Cell. Mol. Life Sci."},{"key":"8854_CR21","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1172\/JCI57990","volume":"122","author":"J Pillay","year":"2012","unstructured":"Pillay, J. et al. A subset of neutrophils in human systemic inflammation inhibits T cell responses through Mac-1. J. Clin. Investig. 122, 327\u2013336. https:\/\/doi.org\/10.1172\/JCI57990 (2012).","journal-title":"J. Clin. Investig."},{"key":"8854_CR22","doi-asserted-by":"publisher","first-page":"1553","DOI":"10.1158\/0008-5472.CAN-08-1921","volume":"69","author":"PC Rodriguez","year":"2009","unstructured":"Rodriguez, P. C. et al. Arginase I-producing myeloid-derived suppressor cells in renal cell carcinoma are a subpopulation of activated granulocytes. Cancer Res. 69, 1553\u20131560. https:\/\/doi.org\/10.1158\/0008-5472.CAN-08-1921 (2009).","journal-title":"Cancer Res."},{"key":"8854_CR23","doi-asserted-by":"publisher","unstructured":"Condamine, T. et al. Lectin-type oxidized LDL receptor-1 distinguishes population of human polymorphonuclear myeloid-derived suppressor cells in cancer patients. Sci. Immunol. 1 https:\/\/doi.org\/10.1126\/sciimmunol.aaf8943 (2016).","DOI":"10.1126\/sciimmunol.aaf8943"},{"key":"8854_CR24","doi-asserted-by":"publisher","unstructured":"Kumar, S. & Dikshit, M. Metabolic insight of neutrophils in health and disease. Front Immunol 10, (2099). https:\/\/doi.org\/10.3389\/fimmu.2019.02099 (2019).","DOI":"10.3389\/fimmu.2019.02099"},{"key":"8854_CR25","doi-asserted-by":"publisher","first-page":"108164","DOI":"10.1016\/j.celrep.2020.108164","volume":"32","author":"C Pfirschke","year":"2020","unstructured":"Pfirschke, C. et al. Tumor-Promoting Ly-6G(+) SiglecF(high) cells are mature and Long-Lived neutrophils. Cell. Rep. 32, 108164. https:\/\/doi.org\/10.1016\/j.celrep.2020.108164 (2020).","journal-title":"Cell. Rep."},{"key":"8854_CR26","doi-asserted-by":"publisher","unstructured":"Mehmeti-Ajradini, M. et al. Human G-MDSCs are neutrophils at distinct maturation stages promoting tumor growth in breast cancer. Life Sci. Alliance. 3 https:\/\/doi.org\/10.26508\/lsa.202000893 (2020).","DOI":"10.26508\/lsa.202000893"},{"key":"8854_CR27","doi-asserted-by":"publisher","unstructured":"Rizo-Tellez, S. A., Sekheri, M., Filep, J. G. & Myeloperoxidase regulation of neutrophil function and target for therapy. Antioxid. (Basel). 11 https:\/\/doi.org\/10.3390\/antiox11112302 (2022).","DOI":"10.3390\/antiox11112302"},{"key":"8854_CR28","doi-asserted-by":"publisher","unstructured":"Arnhold, J. The dual role of myeloperoxidase in immune response. Int. J. Mol. Sci. 21 https:\/\/doi.org\/10.3390\/ijms21218057 (2020).","DOI":"10.3390\/ijms21218057"},{"key":"8854_CR29","doi-asserted-by":"publisher","first-page":"1024","DOI":"10.1016\/j.freeradbiomed.2015.10.398","volume":"89","author":"H Bjornsdottir","year":"2015","unstructured":"Bjornsdottir, H. et al. Neutrophil NET formation is regulated from the inside by myeloperoxidase-processed reactive oxygen species. Free Radic Biol. Med. 89, 1024\u20131035. https:\/\/doi.org\/10.1016\/j.freeradbiomed.2015.10.398 (2015).","journal-title":"Free Radic Biol. Med."},{"key":"8854_CR30","doi-asserted-by":"publisher","first-page":"108052","DOI":"10.1016\/j.pharmthera.2021.108052","volume":"236","author":"P Valadez-Cosmes","year":"2022","unstructured":"Valadez-Cosmes, P. et al. Growing importance in cancer pathogenesis and potential drug target. Pharmacol. Ther. 236, 108052. https:\/\/doi.org\/10.1016\/j.pharmthera.2021.108052 (2022).","journal-title":"Pharmacol. Ther."},{"key":"8854_CR31","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1007\/s10549-008-9962-z","volume":"113","author":"C He","year":"2009","unstructured":"He, C., Tamimi, R. M., Hankinson, S. E., Hunter, D. J. & Han, J. A prospective study of genetic polymorphism in MPO, antioxidant status, and breast cancer risk. Breast Cancer Res. Treat. 113, 585\u2013594. https:\/\/doi.org\/10.1007\/s10549-008-9962-z (2009).","journal-title":"Breast Cancer Res. Treat."},{"key":"8854_CR32","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1007\/s10549-019-05336-3","volume":"177","author":"J Zeindler","year":"2019","unstructured":"Zeindler, J. et al. Infiltration by myeloperoxidase-positive neutrophils is an independent prognostic factor in breast cancer. Breast Cancer Res. Treat. 177, 581\u2013589. https:\/\/doi.org\/10.1007\/s10549-019-05336-3 (2019).","journal-title":"Breast Cancer Res. Treat."},{"key":"8854_CR33","doi-asserted-by":"publisher","DOI":"10.1093\/jleuko\/qiad152","author":"E Kallberg","year":"2023","unstructured":"Kallberg, E. et al. AIRE is expressed in breast cancer tans and TAMs to regulate the extrinsic apoptotic pathway and inflammation. J. Leukoc. Biol. https:\/\/doi.org\/10.1093\/jleuko\/qiad152 (2023).","journal-title":"J. Leukoc. Biol."},{"key":"8854_CR34","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s13058-023-01631-6","volume":"25","author":"FB Gunnarsdottir","year":"2023","unstructured":"Gunnarsdottir, F. B. et al. Serum immuno-oncology markers carry independent prognostic information in patients with newly diagnosed metastatic breast cancer, from a prospective observational study. Breast Cancer Res. 25, 29. https:\/\/doi.org\/10.1186\/s13058-023-01631-6 (2023).","journal-title":"Breast Cancer Res."},{"key":"8854_CR35","doi-asserted-by":"publisher","unstructured":"Papadakos, K. S., Hagerling, C., Ryden, L., Larsson, A. M. & Blom, A. M. High levels of expression of cartilage oligomeric matrix protein in lymph node metastases in breast Cancer are associated with reduced survival. Cancers (Basel). 13. https:\/\/doi.org\/10.3390\/cancers13235876 (2021).","DOI":"10.3390\/cancers13235876"},{"key":"8854_CR36","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1186\/s13058-018-0976-0","volume":"20","author":"AM Larsson","year":"2018","unstructured":"Larsson, A. M. et al. Longitudinal enumeration and cluster evaluation of Circulating tumor cells improve prognostication for patients with newly diagnosed metastatic breast cancer in a prospective observational trial. Breast Cancer Res. 20, 48. https:\/\/doi.org\/10.1186\/s13058-018-0976-0 (2018).","journal-title":"Breast Cancer Res."},{"key":"8854_CR37","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.clim.2012.01.011","volume":"143","author":"A Luyckx","year":"2012","unstructured":"Luyckx, A. et al. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin. Immunol. 143, 83\u201387. https:\/\/doi.org\/10.1016\/j.clim.2012.01.011 (2012).","journal-title":"Clin. Immunol."},{"key":"8854_CR38","doi-asserted-by":"publisher","first-page":"1343","DOI":"10.1182\/blood-2016-04-713206","volume":"129","author":"O Marini","year":"2017","unstructured":"Marini, O. et al. Mature CD10(+) and immature CD10(-) neutrophils present in G-CSF-treated donors display opposite effects on T cells. Blood 129, 1343\u20131356. https:\/\/doi.org\/10.1182\/blood-2016-04-713206 (2017).","journal-title":"Blood"},{"key":"8854_CR39","doi-asserted-by":"publisher","unstructured":"Liu, T. W. et al. Inhibition of myeloperoxidase enhances immune checkpoint therapy for melanoma. J. Immunother Cancer. 11 https:\/\/doi.org\/10.1136\/jitc-2022-005837 (2023).","DOI":"10.1136\/jitc-2022-005837"},{"key":"8854_CR40","doi-asserted-by":"publisher","unstructured":"Basnet, A. et al. Targeting myeloperoxidase limits myeloid cell immunosuppression enhancing immune checkpoint therapy for pancreatic cancer. Cancer Immunol. Immunother. 73 https:\/\/doi.org\/10.1007\/s00262-024-03647-z (2024).","DOI":"10.1007\/s00262-024-03647-z"},{"key":"8854_CR41","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1007\/s40487-023-00224-9","volume":"11","author":"P Nunes Filho","year":"2023","unstructured":"Nunes Filho, P., Albuquerque, C., Pilon Capella, M. & Debiasi, M. Immune checkpoint inhibitors in breast cancer: A narrative review. Oncol. Ther. 11, 171\u2013183. https:\/\/doi.org\/10.1007\/s40487-023-00224-9 (2023).","journal-title":"Oncol. Ther."},{"key":"8854_CR42","doi-asserted-by":"publisher","first-page":"107","DOI":"10.1186\/s12943-024-02004-z","volume":"23","author":"X Huang","year":"2024","unstructured":"Huang, X. et al. Neutrophils in Cancer immunotherapy: Friends or foes? Mol. Cancer. 23, 107. https:\/\/doi.org\/10.1186\/s12943-024-02004-z (2024).","journal-title":"Mol. Cancer"},{"key":"8854_CR43","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3389\/fonc.2020.00109","volume":"10","author":"C Bergenfelz","year":"2020","unstructured":"Bergenfelz, C. & Leandersson, K. The generation and identity of human Myeloid-Derived suppressor cells. Front. Oncol. 10, 109. https:\/\/doi.org\/10.3389\/fonc.2020.00109 (2020).","journal-title":"Front. Oncol."},{"key":"8854_CR44","doi-asserted-by":"publisher","first-page":"1941","DOI":"10.3389\/fimmu.2019.01941","volume":"10","author":"H You","year":"2019","unstructured":"You, H., Baluszek, S. & Kaminska, B. Immune microenvironment of brain Metastases-Are microglia and other brain macrophages little helpers?? Front. Immunol. 10, 1941. https:\/\/doi.org\/10.3389\/fimmu.2019.01941 (2019).","journal-title":"Front. Immunol."},{"key":"8854_CR45","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1111\/imr.13176","volume":"314","author":"BB Antuamwine","year":"2023","unstructured":"Antuamwine, B. B. et al. N1 versus N2 and PMN-MDSC: A critical appraisal of current concepts on tumor-associated neutrophils and new directions for human oncology. Immunol. Rev. 314, 250\u2013279. https:\/\/doi.org\/10.1111\/imr.13176 (2023).","journal-title":"Immunol. Rev."},{"key":"8854_CR46","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu, S. Z. et al. A single-cell and spatially resolved atlas of human breast cancers. Nat. Genet. 53, 1334\u20131347. https:\/\/doi.org\/10.1038\/s41588-021-00911-1 (2021).","journal-title":"Nat. Genet."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08854-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08854-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,12]],"date-time":"2025-07-12T16:26:30Z","timestamp":1752337590000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-08854-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,12]]},"references-count":46,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["8854"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-08854-x","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,12]]},"assertion":[{"value":"19 March 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 June 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 July 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"All datasets generated in the course of the current study are presented in the main text and the Supplementary Information available online.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data and materials availability"}},{"value":"This study was performed in accordance with the Declaration of Helsinki and approved by the local Regional Ethical Committee in Lund, Sweden (Dnr 2010\/135).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"A written informed consent was obtained from patients with metastatic breast cancer.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Included patients provided informed consent for publication of results generated.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to publish"}}],"article-number":"25270"}}